Literature DB >> 8397219

Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes.

L Rossetti1, A Giaccari, N Barzilai, K Howard, G Sebel, M Hu.   

Abstract

To examine the relationship between the plasma glucose concentration (PG) and the pathways of hepatic glucose production (HGP), five groups of conscious rats were studied after a 6-h fast: (a) control rats (PG = 8.0 +/- 0.2 mM); (b) control rats (PG = 7.9 +/- 0.2 mM) with somatostatin and insulin replaced at the basal level; (c) control rats (PG = 18.1 +/- 0.2 mM) with somatostatin, insulin replaced at the basal level, and glucose infused to acutely raise plasma glucose by 10 mM; (d) control rats (PG = 18.0 +/- 0.2 mM) with somatostatin and glucose infusions to acutely reproduce the metabolic conditions of diabetic rats, i.e., hyperglycemia and moderate hypoinsulinemia; (e) diabetic rats (PG = 18.4 +/- 2.3 mM). All rats received an infusion of [3-3H]glucose and [U-14C]lactate. The ratio between hepatic [14C]UDP-glucose sp act (SA) and 2X [14C]-phosphoenolpyruvate (PEP) SA (the former reflecting glucose-6-phosphate SA) measured the portion of total glucose output derived from PEP-gluconeogenesis. In control rats, HGP was decreased by 58% in hyperglycemic compared to euglycemic conditions (4.5 +/- 0.3 vs. 10.6 +/- 0.2 mg/kg.min; P < 0.01). When evaluated under identical glycemic conditions, HGP was significantly increased in diabetic rats (18.9 +/- 1.4 vs. 6.2 +/- 0.4 mg/kg.min; P < 0.01). In control rats, hyperglycemia increased glucose cycling (by 2.5-fold) and the contribution of gluconeogenesis to HGP (91% vs. 45%), while decreasing that of glycogenolysis (9% vs. 55%). Under identical plasma glucose and insulin concentrations, glucose cycling in diabetic rats was decreased (by 21%) and the percent contribution of gluconeogenesis to HGP (73%) was similar to that of controls (84%). These data indicate that: (a) hyperglycemia causes a marked inhibition of HGP mainly through the suppression of glycogenolysis and the increase in glucokinase flux, with no apparent changes in the fluxes through gluconeogenesis and glucose-6-phosphatase; under similar hyperglycemic hypoinsulinemic conditions: (b) HGP is markedly increased in diabetic rats; however, (c) the contribution of glycogenolysis and gluconeogenesis to HGP is similar to control animals.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8397219      PMCID: PMC288249          DOI: 10.1172/JCI116681

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  A rapid filter paper assay for UDPglucose-glycogen glucosyltransferase, including an improved biosynthesis of UDP-14C-glucose.

Authors:  J A Thomas; K K Schlender; J Larner
Journal:  Anal Biochem       Date:  1968-10-24       Impact factor: 3.365

2.  Intrinsic regulation of glucose output by rat liver.

Authors:  W H Glinsmann; E P Hern; A Lynch
Journal:  Am J Physiol       Date:  1969-04

Review 3.  Insulin modulation of gene expression.

Authors:  D K Granner; T L Andreone
Journal:  Diabetes Metab Rev       Date:  1985

4.  Importance of glucose per se to intravenous glucose tolerance. Comparison of the minimal-model prediction with direct measurements.

Authors:  M Ader; G Pacini; Y J Yang; R N Bergman
Journal:  Diabetes       Date:  1985-11       Impact factor: 9.461

5.  Hyperglycemia inhibits glucose production in man independent of changes in glucoregulatory hormones.

Authors:  L Sacca; R Hendler; R S Sherwin
Journal:  J Clin Endocrinol Metab       Date:  1978-11       Impact factor: 5.958

6.  Effects of hyperglycemia on glucose production and utilization in humans. Measurement with [23H]-, [33H]-, and [614C]glucose.

Authors:  P M Bell; R G Firth; R A Rizza
Journal:  Diabetes       Date:  1986-06       Impact factor: 9.461

7.  Glucose disposal during insulinopenia in somatostatin-treated dogs. The roles of glucose and glucagon.

Authors:  G I Shulman; J E Liljenquist; P E Williams; W W Lacy; A D Cherrington
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

8.  Effect of glucose, independent of changes in insulin and glucagon secretion, on alanine metabolism in the conscious dog.

Authors:  G I Shulman; W W Lacy; J E Liljenquist; U Keller; P E Williams; A D Cherrington
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

9.  Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release.

Authors:  S Bonner-Weir; D F Trent; G C Weir
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

10.  Glucose and fructose 6-phosphate cycle in humans.

Authors:  S Karlander; A Roovete; M Vranić; S Efendić
Journal:  Am J Physiol       Date:  1986-11
View more
  45 in total

1.  Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans. A stable isotope study.

Authors:  M K Hellerstein; R A Neese; P Linfoot; M Christiansen; S Turner; A Letscher
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production.

Authors:  Michael W Rajala; Silvana Obici; Philipp E Scherer; Luciano Rossetti
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

Review 3.  Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony.

Authors:  Mark A Herman; Barbara B Kahn
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

4.  Critical role of STAT3 in leptin's metabolic actions.

Authors:  Christoph Buettner; Alessandro Pocai; Evan D Muse; Anne M Etgen; Martin G Myers; Luciano Rossetti
Journal:  Cell Metab       Date:  2006-07       Impact factor: 27.287

5.  Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene.

Authors:  L Rossetti; A E Stenbit; W Chen; M Hu; N Barzilai; E B Katz; M J Charron
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

6.  Effect of hypoglycemia on brain glycogen metabolism in vivo.

Authors:  In-Young Choi; Elizabeth R Seaquist; Rolf Gruetter
Journal:  J Neurosci Res       Date:  2003-04-01       Impact factor: 4.164

7.  Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus.

Authors:  M Mevorach; A Giacca; Y Aharon; M Hawkins; H Shamoon; L Rossetti
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

8.  In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats.

Authors:  L Rossetti; M Hawkins; W Chen; J Gindi; N Barzilai
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

9.  Excessive glucose production, rather than insulin resistance, accounts for hyperglycaemia in recent-onset streptozotocin-diabetic rats.

Authors:  R Burcelin; M Eddouks; J Maury; J Kande; R Assan; J Girard
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

10.  The set point for maternal glucose homeostasis is lowered during late pregnancy in the rat: the role of the islet beta-cell and liver.

Authors:  C J Nolan; J Proietto
Journal:  Diabetologia       Date:  1996-07       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.